These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21340593)

  • 1. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].
    May M; Fritsche HM; Gilfrich C; Brookman-May S; Burger M; Otto W; Bolenz C; Trojan L; Herrmann E; Michel MS; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Müller O; Bretschneider-Ehrenberg P; Zacharias M; Gunia S; Bastian PJ
    Urologe A; 2011 Jul; 50(7):821-9. PubMed ID: 21340593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
    Otto W; May M; Fritsche HM; Dragun D; Aziz A; Gierth M; Trojan L; Herrmann E; Moritz R; Ellinger J; Tilki D; Buchner A; Höfner T; Brookman-May S; Nuhn P; Gilfrich C; Roigas J; Zacharias M; Denzinger S; Hohenfellner M; Haferkamp A; Müller SC; Kocot A; Riedmiller H; Wieland WF; Stief CG; Bastian PJ; Burger M
    Gend Med; 2012 Dec; 9(6):481-9. PubMed ID: 23217567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management.
    Pietzak EJ; Hwang WT; Malkowicz SB; Guzzo TJ
    Ann Surg Oncol; 2014 Dec; 21(13):4383-9. PubMed ID: 25047468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
    Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M
    Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
    Mason RJ; Frank I; Bhindi B; Tollefson MK; Thompson RH; Karnes RJ; Tarrell R; Thapa P; Boorjian SA
    World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-dependent cancer-specific survival following radical cystectomy.
    May M; Stief C; Brookman-May S; Otto W; Gilfrich C; Roigas J; Zacharias M; Wieland WF; Fritsche HM; Hofstädter F; Burger M
    World J Urol; 2012 Oct; 30(5):707-13. PubMed ID: 21984471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
    Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
    Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
    May M; Herrmann E; Bolenz C; Brookman-May S; Tiemann A; Moritz R; Fritsche HM; Burger M; Trojan L; Michel MS; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Bastian PJ
    Ann Surg Oncol; 2011 Jul; 18(7):2018-25. PubMed ID: 21246405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
    Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
    J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.